Alx Oncology Holdings (ALXO) Current Assets (2019 - 2026)

Alx Oncology Holdings has reported Current Assets for 8 years, with the latest figure at $145.6 million in Q1 2026.

• Quarterly Current Assets rose 41.97% year-over-year to $145.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.6 million (up 41.97% YoY) and the FY2025 annual result came in at $50.7 million, down 62.24% from the prior year.
• Current Assets climbed to $145.6 million in Q1 2026 per ALXO's latest filing, from $50.7 million in the prior quarter.
• Over five years, Current Assets peaked at $321.5 million in Q1 2022 and troughed at $50.7 million in Q4 2025.
• A 5-year average of $183.4 million and a median of $168.7 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2025 and 2026: Current Assets tumbled 62.24% in 2025, then soared 41.97% in 2026.
• Over 5 years, Current Assets stood at $271.0 million in 2022, then slumped by 30.38% to $188.7 million in 2023, then fell by 28.79% to $134.4 million in 2024, then sank by 62.24% to $50.7 million in 2025, then surged by 186.96% to $145.6 million in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $145.6 million, $50.7 million, and $66.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.